Headquartered in Newtown, PA Fiscal year ends December NASDAQ: HSDT solanacompany.co
Solana Company (Nasdaq: HSDT), formerly Helius Medical Technologies, is a publicly listed digital asset treasury, infrastructure and services company providing institutional access to the Solana blockchain ecosystem. Its stated goal is to maximize SOL per share.
The business combines three activities:
- active management of a treasury of roughly 2.4 million SOL;
- institutional-grade staking and validator operations through its Pacific Backbone infrastructure, which also accepts third-party delegated stake;
- bespoke advisory and education services for banks, asset managers and exchanges adopting blockchain, with a focus on Asia-Pacific and a new headquarters in Hong Kong.
Revenue is now generated primarily from staking rewards. The company divested its legacy PoNS (Portable Neuromodulation Stimulator) medical device business. It uses equity issuance at premiums to NAV and share repurchases below NAV to grow SOL holdings per share. Updated
XRP and Solana both sit about 71% below their peaks after nearly identical monthly slides, yet their paths back look very different. ETF outflows, escrow releases, and one key moving average could…
Sam Daodu Solana Company (Nasdaq: HSDT), formerly Helius Medical Technologies, is a publicly listed digital asset treasury, infrastructure and services company providing institutional access to the Solana blockchain ecosystem. Its stated goal is to maximize SOL per share.
The Wall Street consensus 12-month price target for HSDT is $3.50.